Publication | Open Access
Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma
27
Citations
18
References
2018
Year
S100A14 increases the motility of lung adenocarcinoma cells, and might be a diagnostic and prognostic serum biomarker and potential therapeutic target for lung adenocarcinoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1